68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax. (Q51497535)

5 April 2018

title

68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax. (English)

1 reference

5 April 2018

5

Nicole Unger

1 reference

5 April 2018

Andreas Bockisch

10

object named as

Andreas Bockisch

1 reference

5 April 2018

Gerald Antoch

9

object named as

Gerald Antoch

1 reference

5 April 2018

author name string

Christian Boy

1

1 reference

5 April 2018

Till A Heusner

2

1 reference

5 April 2018

Thorsten D Poeppel

3

1 reference

5 April 2018

Anja Redmann-Bischofs

4

1 reference

5 April 2018

Walter Jentzen

6

1 reference

5 April 2018

Wolfgang Brandau

7

1 reference

5 April 2018

Klaus Mann

8

1 reference

5 April 2018

Stephan Petersenn

11

1 reference

5 April 2018

publication date

3 March 2011

1 reference

5 April 2018

number of pages

13

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

5 April 2018

volume

38

1 reference

5 April 2018

issue

7

1 reference

5 April 2018

page(s)

1224-1236

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1007/s00259-011-1760-x

exact match

0 references

cites work

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

1 reference

12 December 2020

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

1 reference

12 December 2020

The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals

1 reference

12 December 2020

Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies

1 reference

12 December 2020

Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney

1 reference

12 December 2020

Classification and nomenclature of somatostatin receptors

1 reference

12 December 2020

Measurement of gut hormonal peptides in biopsies from human stomach and proximal small intestine

1 reference

12 December 2020

Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy

1 reference

12 December 2020

Dosimetry for treatment with radiolabelled somatostatin analogues. A review.

1 reference

12 December 2020

Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions

1 reference

12 December 2020

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

1 reference

12 December 2020

Somatostatin receptor subtype expression in the human heart: differential expression by myocytes and fibroblasts

1 reference

12 December 2020

Autonomic neurotransmission: 60 years since sir Henry Dale

1 reference

12 December 2020

In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors.

1 reference

12 December 2020

Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas.

1 reference

12 December 2020

The somatostatin receptor in the GI tract

1 reference

12 December 2020

Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland

1 reference

12 December 2020

Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors

1 reference

12 December 2020

Somatostatin receptors

1 reference

12 December 2020

Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats.

1 reference

12 December 2020

Architectonics of the human cerebral cortex and transmitter receptor fingerprints: reconciling functional neuroanatomy and neurochemistry.

1 reference

12 December 2020

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

1 reference

12 December 2020

The role of cortistatin in the human immune system

1 reference

12 December 2020

Processing of generator-produced 68Ga for medical application.

1 reference

12 December 2020

Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans.

1 reference

12 December 2020

Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.

1 reference

12 December 2020

Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer

1 reference

12 December 2020

Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland.

1 reference

12 December 2020

Somatostatin and its receptors in the development of the endocrine pancreas

1 reference

12 December 2020

Clinical endocrinology and metabolism. The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders

1 reference

12 December 2020

Somatostatin and its receptor family

1 reference

12 December 2020

The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells

1 reference

12 December 2020

68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy

1 reference

12 December 2020

Analysis of emission tomographic scan data: limitations imposed by resolution and background

1 reference

12 December 2020

Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.

1 reference

12 December 2020

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

12 December 2020

Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging.

1 reference

12 December 2020

10.1007/S00259-011-1760-X

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

21369945

1 reference

5 April 2018